A
Agilent Tech (A)
NYSE
$126.71+$0.22 (+0.17%)
Price as of Jun 23, 2026 3:37 PM EDT
  • $35.7B
    Market Cap
  • 9.82%
    1-Year Change
  • Diagnostics & Research
    Industry

Key Performance

More
  • Earnings Score: 49
  • Momentum Score: 76
  • True Yield: 37
  • Financial Health Score: 35
TradeSmith Loading

Latest Research & News

Global Automated Liquid Handling Systems Market Size/Share Worth USD 6.9 Billion by 2035 at a 9.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global automated liquid handling systems market is valued at USD 2.7 billion in 2025 and is projected to reach USD 6.9 billion by 2035, growing at a CAGR of 9.8%. Growth is driven by increasing pharmaceutical R&D, clinical trials, technological advancements, and demand for automation in diagnostics and molecular testing. Key players include Eppendorf SE, PerkinElmer Inc., Thermo Fisher Scientific Inc., and QIAGEN NV.

06/18/2026, 10:30 PM • GlobeNewswire

Stock Market Today: S&P 500, Dow Futures Inch Up As US-Iran Deal Awaits Trump Approval — Dell, Agilent, Hewlett Packard Enterprise In Focus

U.S. stock futures edged up on Friday as investors monitored Iran ceasefire developments awaiting Trump approval. Major indexes posted modest gains with healthcare, IT, and consumer discretionary leading. Dell surged nearly 40% on strong earnings, while Agilent and Hewlett Packard Enterprise also gained. Costco reported mixed results with earnings slightly below estimates. The Fed is expected to hold rates steady in June with 98.9% probability.

05/29/2026, 5:39 AM • Benzinga

Why Agilent Technologies Stock Triumphed on Thursday

Agilent Technologies stock surged 17.25% on Thursday following strong Q2 2026 earnings results. The company reported $1.83 billion in revenue (up 10% YoY) and $1.49 per share in adjusted net income (up 14% YoY), beating analyst expectations on both metrics. All three business segments showed growth, with Applied Markets Group leading at 14%. Management raised full-year 2026 guidance for both revenue and adjusted net income.

05/28/2026, 8:07 PM • The Motley Fool

S&P 500 Hits Record Highs, Snowflake Jumps 37% On AI Boom: Stock Market Today

U.S. stocks reached record highs on Thursday following geopolitical news of a ceasefire extension. The S&P 500 advanced 0.5% to 7,557.85, driven by an AI software spending spree. Snowflake surged 37% after beating earnings estimates and announcing a $6 billion AWS partnership expansion. Other notable gainers included Best Buy (+18%), Dollar Tree (+17%), and Agilent Technologies (+17%). However, mixed economic data showed headline PCE inflation at 3.8% while core PCE and consumer spending remained subdued, prompting hawkish Fed commentary.

05/28/2026, 12:58 PM • Benzinga

Tissue Diagnostics Market to Reach USD 9.33 Bn by 2031 Driven by Expanding Precision Oncology Applications and Rising Adoption of Digital Pathology, Says Mordor Intelligence

The global tissue diagnostics market is projected to grow from USD 6.45 billion in 2025 to USD 9.33 billion by 2031, with a CAGR of 6.35%. Growth is driven by increasing cancer prevalence, rising adoption of precision medicine, advancements in digital pathology and AI-assisted diagnostics, and expanding biomarker-based testing. North America leads the market while Asia-Pacific emerges as a high-growth region.

05/21/2026, 3:37 AM • GlobeNewswire

Global DNA Microarray Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2034 | DelveInsight

The global DNA microarray market is expected to grow from USD 2.5 billion in 2025 to USD 4.7 billion by 2034 at a CAGR of ~7%. Growth is driven by rising demand for genomic research, personalized medicine, early disease diagnosis, and increasing prevalence of cancer and genetic disorders. North America leads the market with 41.39% share, while Asia-Pacific emerges as a key growth contributor.

05/06/2026, 1:00 PM • GlobeNewswire

Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - Asia-Pacific NGS Market Poised for Fastest Growth, Driven by Large-Scale Genomic Projects and the Rising Need for Precision Medicine

The global NGS market is projected to reach USD 29.53 billion by 2030 from USD 14.94 billion in 2025, growing at a CAGR of 14.6%. Growth is driven by expanding applications in oncology, infectious diseases, and precision medicine, with Asia-Pacific exhibiting the fastest regional growth. Consumables dominate the product segment, while academic and research institutes lead the services end-user segment.

04/10/2026, 5:45 AM • GlobeNewswire

Deal Dispatch: Papa John's May Go Private, Shell Buys Jiffy Lube, Meta Acquires Moltbook

Multiple major M&A transactions are underway across various sectors. Papa John's received a $1.5 billion privatization proposal from Irth Capital Management backed by Brookfield Asset Management. Shell sold Jiffy Lube to Monomoy Capital Partners for $1.3 billion. Meta acquired AI social network Moltbook, while Google completed its $32 billion acquisition of cloud security platform Wiz. Other notable deals include Agilent acquiring Biocare Medical for $950 million and Universal Health Services acquiring Talkspace for $835 million. Meanwhile, several retailers including Eddie Bauer and Saks Global are closing stores amid bankruptcy proceedings.

03/13/2026, 2:29 PM • Benzinga

Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence

The global molecular diagnostics market is projected to reach USD 33.51 billion by 2031, growing at a CAGR of 10.43% from 2026 to 2031. Growth is driven by increasing adoption of precision medicine, advancements in genomic testing technologies, and rising prevalence of infectious and chronic diseases. North America leads the market while Asia-Pacific is expected to be the fastest-growing region.

03/10/2026, 3:32 AM • GlobeNewswire

Agilent Bets On Pathology Innovation With Biocare Acquisition

Agilent Technologies announced the acquisition of Biocare Medical for approximately $950 million to strengthen its pathology and immunohistochemistry offerings. The deal is expected to close by Q4 fiscal 2026 and become accretive to EPS within 12 months. However, Agilent's stock has declined 5.60% over the past year and is currently trading below key moving averages, showing weak momentum despite the strategic acquisition.

03/09/2026, 6:12 AM • Benzinga

[Latest] Global Microplate Systems Market Size/Share Worth USD 2.88 Billion by 2035 at a 10.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global microplate systems market was valued at USD 1.42 billion in 2025 and is projected to reach USD 2.88 billion by 2035, growing at a CAGR of 10.7%. Growth is driven by increased R&D spending in pharmaceuticals, rising demand for high-throughput screening in drug discovery, and innovations in multimode detection systems and automation. Key players include Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer, and Bio-Rad Laboratories.

03/03/2026, 6:30 PM • GlobeNewswire

Chromatography Research Report 2026 - Global $13.69 Bn Market Trends, Opportunities, and Forecasts to 2031

The global chromatography market is projected to grow from USD 10.03 billion in 2025 to USD 13.69 billion by 2031 at a CAGR of 5.32%, driven by expanding R&D in pharma/biotech and strict food safety regulations. However, high capital costs limit adoption among smaller entities. Emerging trends include green chromatography and AI-powered method optimization.

01/30/2026, 4:59 AM • GlobeNewswire

Automated Sample Preparation Research Report 2026 - Global $4.31 Bn Market Trends, Opportunities, and Forecasts to 2031

The global automated sample preparation market is expected to expand at a 10.10% CAGR from 2025 to 2031, driven by pharmaceutical R&D investments, need for reproducibility, and AI/ML adoption. However, high initial costs and integration challenges with legacy systems remain significant barriers, particularly for smaller laboratories and SMEs.

01/30/2026, 4:56 AM • GlobeNewswire

Microarrays Market Size to Accumulate Around USD 10.72 Billion by 2033, Driven by Expanding Genomics Research and Advanced Diagnostic Adoption – SNS Insider

The global microarrays market is projected to grow from USD 6.16 billion in 2025 to USD 10.72 billion by 2033, at a CAGR of 7.24%. Growth is driven by increasing adoption of genomics and proteomics research, drug discovery applications, and disease diagnostics. North America dominates with 43% market share, while Asia Pacific emerges as the fastest-growing region with a 9.54% CAGR.

01/26/2026, 11:00 AM • GlobeNewswire

Anatomic Pathology Market Research: Global and Regional Insights, Competition, Forecast and Opportunities, 2025-2033 | Astute Analytica

The global anatomic pathology market is projected to grow from $93.03 billion in 2024 to $224.44 billion by 2033 at a CAGR of 10.28%, driven by rising cancer burden, aging populations, and AI-powered digital pathology adoption. North America leads with over 41% market share, supported by advanced healthcare infrastructure and precision oncology investments. Disease diagnostics account for 74.42% of revenue, with cancer diagnostics representing 60% of biopsy applications globally.

01/22/2026, 1:54 PM • GlobeNewswire

Peers

Statistics

More
Day Range
$125.57
$127.90
$126.49
1-Year Range
$110.24
$157.20
$126.49
Latest Close$126.49
Change
-$0.57 (-0.45%)
Volume2,187,147
Market Cap$35.7B
Shares Outstanding282.4M
P/E (TTM)25.38
Diluted EPS (TTM)$4.98
Enterprise Value$37.3B

Information as of 06/22/2026

Company Profile

AGILENT TECHNOLOGIES INC
AGILENT TECHNOLOGIES INC
https://www.agilent.com
$35.7B
Market Cap
$1.4B
Net Income
Sector: Healthcare
Industry: Diagnostics & Research
5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051
800 227 9770

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Key Executives

  • Padraig McDonnell
  • Simon May
  • Bret DiMarco
  • Michael Buckner
  • Angelica Riemann

Current Ownership Distribution

  • Institutions4.6B (70.81%)
  • Mutual Funds1.9B (29.13%)
  • Insiders3.7M (0.06%)
  • Other0 (0.00%)